Sarepta Therapeutics is a pioneer in gene therapy for muscular dystrophy. They developed the first FDA approved treatment, and their scientific discoveries have been revolutionary. We developed the corporate brand and website to tell their story. An iconic look and new voice launched promotion, social, news releases, scientific papers, and symposia. Their chairman often says, “The competition isn’t the enemy. The disease is.” We wanted this work to live up to that beautiful idea.

A digital wallboard in the Sarepta Therapeutics headquarters, Cambridge, MA

The website is as much about purpose as science, demonstrating Sarepta’s sense of urgency in its mission. The product section is built as an interactive pipeline. The target graph changes to reflect the number of therapies under development and their progress. Clinical study data is accessible under each therapy.

Digital and traditional work adhered to a very tight design aesthetic quickly establishing and differentiating Sarepta from other biotechnology companies working in the field of gene therapy.